Diagnosis and Treatment > Medication > Ginkgo biloba
You are looking at 1 - 1 of 1 items
Search for other papers by Jiman Kim in
Google Scholar
PubMed
Search for other papers by Eulsun Moon in
Google Scholar
PubMed
Search for other papers by Seungwon Kwon in
Google Scholar
PubMed
Summary
Diabetic nephropathy, a microvascular complication of diabetes, is a progressive kidney disease caused by angiopathy of the capillaries in the kidney glomeruli. Herein, we report a case of a 62-year-old patient with a 30 year history of diabetes, who showed a substantial improvement in diabetic nephropathy on administration of 30 g of Astragalus membranaceus extract per day. After 1 month, estimated glomerular filtration rate increased from 47 to 72 ml/min per 1.73 m2 and was subsequently maintained at the 1-month follow-up. Urinary protein levels also decreased following treatment. Herein, we present and discuss the evidence and mechanism of A. membranaceus on diabetic nephropathy in this patient.
Learning points
Diabetic nephropathy is a progressive kidney disease.
Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) are currently used to prevent and delay the progression of diabetic nephropathy. However, their effects are not sufficient to prevent a decline in kidney function.
Furthermore, combination therapy with an ACE inhibitor and an ARB can produce adverse effects without additional benefits.
In the early phase of diabetic nephropathy, administration of Astragalus membranaceus can be a therapeutic option.